TGIF2 Antibodies

Santa Cruz Biotechnology offers a broad range of TGIF2 monoclonal antibodies for research focused on understanding TGIF2 protein function. TGIF2 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TGIF2, or TG-interacting factor 2, is a transcriptional repressor that plays a critical role in the regulation of gene expression during embryonic development and cellular differentiation. TGIF2 participates in various signaling pathways, including those related to TGF-beta, and has been implicated in several diseases, including cancer. Research has shown that TGIF2 influences multiple cellular processes through its interaction with various molecular partners. Scientists continue to uncover new aspects of TGIF2 biology, from its role in development to its potential as a therapeutic target. Understanding TGIF2 function and regulation provides valuable insights into developmental processes and disease mechanisms. Recent studies have highlighted TGIF2's significance in cell fate decisions and tissue homeostasis. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of TGIF2's role in health and disease.